Statin-fibrate combinations in patients with combined hyperlipidemia

被引：20

作者：

Athyros, VG ^{[1
]}

Papageorgiou, AA ^{[1
]}

Kontopoulos, AC ^{[1
]}

机构：

[1] Aristotelian Univ Salonika, Hippocrat Hosp, Pr Dept Internal Med 2, Div Cardiol,Lipid Out Patient Clin, Thessaloniki 54642, Greece

来源：

ATHEROSCLEROSIS | 2001年 / 155卷 / 01期

关键词：

D O I：

10.1016/S0021-9150(00)00726-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：263 / 264

页数：2

相关论文

共 3 条

[1] Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia
Athyros, VG
Papageorgiou, AA
Hatzikonstandinou, HA
Didangelos, TP
Carina, MV
Kranitsas, DF
Kontopoulos, AG
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (05) : 608 - 613
[2] Effects of simvastatin and ciprofibrate alone and in combination on lipid profile, plasma fibrinogen and low density lipoprotein particle structure and distribution in patients with familial combined hyperlipidaemia and coronary artery disease
Kontopoulos, AG
Athyros, VG
Papageorgiou, AA
Hatzikonstandinou, HA
Mayroudi, MC
Boudoulas, H
[J]. CORONARY ARTERY DISEASE, 1996, 7 (11) : 843 - 850
[3] Efficacy and safety of a combination of fluvastatin and bezafibrate in patients with mixed hyperlipidaemia (FACT study)
Pauciullo, P
Borgnino, C
Paoletti, R
Mariani, M
Mancini, M
[J]. ATHEROSCLEROSIS, 2000, 150 (02) : 429 - 436